# Umbilical Cord Blood Transplant for Hematological Malignancies

> **NCT00891592** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 5 (actual)

## Conditions studied

- CML
- AML
- MDS
- ALL
- NHL
- Multiple Myeloma
- Hodgkin's Disease

## Interventions

- **BIOLOGICAL:** Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
- **OTHER:** Observation Arm

## Key facts

- **NCT ID:** NCT00891592
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-11
- **Final completion:** 2016-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2016-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891592, "Umbilical Cord Blood Transplant for Hematological Malignancies". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00891592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*